Hydralazine-Associated ANCA/Lupus-Like Overlap Nephritis: Equivocal Serology, Defining Pathology (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0769; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He received cyclophosphamide induction and was transitioned to rituximab. However, negative ANA and anti-dsDNA made classic drug-induced lupus nephritis less convincing. Kidney biopsy resolved the ambiguity by demonstrating both necrotizing crescentic GN and mesangiopathic immune-complex GN, guiding hydralazine withdrawal and immunosuppression."
ANCA Vasculitis • Cardiovascular • Coronary Artery Disease • Diabetes • Diabetic Nephropathy • Glomerulonephritis • Hematological Disorders • Hypertension • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Metabolic Disorders • Nephrology • Pulmonary Disease • Renal Disease • Type 2 Diabetes Mellitus • Vasculitis
|
|
Paul Luong; Alyssa Davis Steitz; Gautam B. Bhave; Paisit Paueksakon; Fabian Bock
|